Načítá se...
NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis
BACKGROUND: Although novel therapeutic regimens for melanoma continue to emerge, the best current clinical response rate is still less than 60%. Moreover, antimelanoma treatments contribute to toxicities in other vital organs. In this study, we elucidate the therapeutic advantages of siRNA targeting...
Uloženo v:
| Vydáno v: | J Cancer Sci Clin Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7497821/ https://ncbi.nlm.nih.gov/pubmed/32954352 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.26502/jcsct.5079070 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|